IL159585A0 - Single dose azithromycin for treating respiratory infections - Google Patents

Single dose azithromycin for treating respiratory infections

Info

Publication number
IL159585A0
IL159585A0 IL15958502A IL15958502A IL159585A0 IL 159585 A0 IL159585 A0 IL 159585A0 IL 15958502 A IL15958502 A IL 15958502A IL 15958502 A IL15958502 A IL 15958502A IL 159585 A0 IL159585 A0 IL 159585A0
Authority
IL
Israel
Prior art keywords
single dose
respiratory infections
treating respiratory
dose azithromycin
azithromycin
Prior art date
Application number
IL15958502A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of IL159585A0 publication Critical patent/IL159585A0/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
IL15958502A 2001-08-21 2002-07-31 Single dose azithromycin for treating respiratory infections IL159585A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31386701P 2001-08-21 2001-08-21
PCT/IB2002/003076 WO2003018031A2 (fr) 2001-08-21 2002-07-31 Azithromycine unidose

Publications (1)

Publication Number Publication Date
IL159585A0 true IL159585A0 (en) 2004-06-01

Family

ID=23217490

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15958502A IL159585A0 (en) 2001-08-21 2002-07-31 Single dose azithromycin for treating respiratory infections

Country Status (25)

Country Link
US (3) US20030148964A1 (fr)
EP (1) EP1418924A2 (fr)
JP (1) JP2005501862A (fr)
KR (1) KR20040032942A (fr)
AP (1) AP1729A (fr)
BG (1) BG108537A (fr)
BR (1) BR0211830A (fr)
CA (1) CA2458135A1 (fr)
CZ (1) CZ2004232A3 (fr)
EA (1) EA200400214A1 (fr)
EC (1) ECSP044985A (fr)
GE (1) GEP20063812B (fr)
HR (1) HRP20040163A2 (fr)
HU (1) HUP0401332A2 (fr)
IL (1) IL159585A0 (fr)
IS (1) IS7092A (fr)
MA (1) MA27059A1 (fr)
MX (1) MXPA04001605A (fr)
OA (1) OA12845A (fr)
PL (1) PL367888A1 (fr)
SK (1) SK1012004A3 (fr)
TN (1) TNSN04035A1 (fr)
WO (1) WO2003018031A2 (fr)
YU (1) YU8804A (fr)
ZA (1) ZA200400804B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE602004019288D1 (de) * 2003-07-24 2009-03-19 Pliva Hrvatska D O O Schnellösliches azithromycin in einzeldosisform
CA2547597A1 (fr) 2003-12-04 2005-06-16 Pfizer Products Inc. Compositions multiparticulaires a stabilite amelioree
ES2308274T3 (es) 2003-12-04 2008-12-01 Pfizer Products Inc. Procedimiento para fabricar multiparticulados farmaceuticos.
US20060116336A1 (en) * 2004-03-17 2006-06-01 American Pharmaceutical Partners, Inc. Lyophilized azithromycin formulation
US7468428B2 (en) * 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
CA2838111C (fr) 2005-12-08 2016-01-19 Insmed Incorporated Compositions a base de lipide d'anti-infectieux pour traiter des infections pulmonaires et procedes d'utilisation de celles-ci
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
US20090005326A1 (en) * 2007-06-26 2009-01-01 Idexx Laboratories, Inc. Single dose roxithromycin
US20090197956A1 (en) * 2008-02-04 2009-08-06 Arbor Pharmaceuticals, Inc. Treatment of acute otitis media with xylitol and n-acetylcysteine
US20110105421A1 (en) * 2008-03-14 2011-05-05 The Florida International University Board Of Trustees Ellagitannins as inhibitors of bacterial quorum sensing
US20130156803A1 (en) 2011-06-04 2013-06-20 Rochester General Hospital Research Institute Compositions and methods related to p6
EP3581186A1 (fr) 2012-11-29 2019-12-18 Insmed Incorporated Formulations de vancomycine stabilisées
PL3142643T3 (pl) * 2014-05-15 2019-12-31 Insmed Incorporated Sposoby leczenia zakażeń płuc prątkami niegruźliczymi
EP3773505A4 (fr) 2018-03-30 2021-12-22 Insmed Incorporated Procédés pour la fabrication continue de produits médicamenteux liposomaux
WO2021163451A1 (fr) * 2020-02-14 2021-08-19 Asklepios Biopharmaceutical, Inc. Procédé de traitement d'une toxicité associée à une thérapie génique avec des antibiotiques

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US53264A (en) * 1866-03-20 Improved ditching-machine
YU43116B (en) * 1979-04-02 1989-04-30 Pliva Pharm & Chem Works Process for preparing 11-aza-4-o-cladinosyl-6-o-desosaminyl-15-ethyl-7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl-oxacyclopentadecane-2-one(11-aza-10-deox
SI8110592A8 (en) * 1981-03-06 1996-06-30 Pliva Pharm & Chem Works Process for preparing of n-methyl-11-aza-10-deoxo-10-dihydroerythromycine a and derivatives thereof
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
RU2066324C1 (ru) * 1987-07-09 1996-09-10 Пфайзер Инк. Кристаллический дигидрат азитромицина и способ его получения
WO1989002271A1 (fr) * 1987-09-10 1989-03-23 Pfizer Azithromycine et derives utilises comme agents anti-protozoaires
YU45590A (sh) * 1990-03-07 1992-07-20 PLIVA FARMACEVTSKA, KEMIJSKA, PREHRAMBENA I KOZMETIČKA INDUSTRIJA s.p.o. Novi kompleksi odnosno helati antibiotika s dvovalentnim i/ili trovalentnim metalima i postupci za njihovo dobijanje
TW271400B (fr) * 1992-07-30 1996-03-01 Pfizer
DE69403963T2 (de) * 1993-05-19 1997-11-20 Pfizer Zwischenprodukt für azithromycin
US5605889A (en) * 1994-04-29 1997-02-25 Pfizer Inc. Method of administering azithromycin
CZ292360B6 (cs) * 1994-05-06 2003-09-17 Pfizer Inc. Dávkovací forma s řízeným uvolňováním obsahující azithromycin a způsob její výroby
HRP980189B1 (en) * 1998-04-06 2004-04-30 Pliva Pharm & Chem Works Novel 15-membered lactams ketolides
US6239113B1 (en) * 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
US20040053264A1 (en) * 2002-02-01 2004-03-18 Park Sung Sup Clinical panel assay using DNA chips

Also Published As

Publication number Publication date
PL367888A1 (en) 2005-03-07
CA2458135A1 (fr) 2003-03-06
WO2003018031A2 (fr) 2003-03-06
US6987093B2 (en) 2006-01-17
EP1418924A2 (fr) 2004-05-19
ECSP044985A (es) 2004-04-28
AP2004002968A0 (en) 2004-03-31
AP1729A (en) 2007-03-26
YU8804A (sh) 2006-08-17
CZ2004232A3 (cs) 2005-10-12
HRP20040163A2 (en) 2005-02-28
GEP20063812B (en) 2006-05-10
BR0211830A (pt) 2004-09-08
EA200400214A1 (ru) 2004-06-24
US7067493B2 (en) 2006-06-27
WO2003018031A3 (fr) 2003-10-02
MA27059A1 (fr) 2004-12-20
BG108537A (bg) 2005-02-28
OA12845A (en) 2006-09-15
US20050250712A1 (en) 2005-11-10
US20030148964A1 (en) 2003-08-07
IS7092A (is) 2003-12-23
SK1012004A3 (sk) 2005-04-01
KR20040032942A (ko) 2004-04-17
MXPA04001605A (es) 2004-07-08
US20040023898A1 (en) 2004-02-05
ZA200400804B (en) 2005-05-03
JP2005501862A (ja) 2005-01-20
TNSN04035A1 (fr) 2006-06-01
HUP0401332A2 (hu) 2004-11-29

Similar Documents

Publication Publication Date Title
GB0123951D0 (en) Therapies for treating respiratory diseases
GB2371462B (en) Radiation treatment system
IL161405A0 (en) Substituted diphenyl heterocycles useful, for treating hcv infection
AU4579401A (en) Lung treatment apparatus
IL165891A0 (en) 2' and 3'-nucleoside prodrugs for treating flaviviridae infections
AU2002360251A8 (en) Medical devices comprising nanocomposites
AU2002342613A8 (en) Treatment for wounds
IL159585A0 (en) Single dose azithromycin for treating respiratory infections
EP1357583A4 (fr) Dispositif de traitement a feuilles
EP1422743A4 (fr) Systeme de traitement
GB2372947B (en) Air treatment unit
HUP0202396A3 (en) Medicaments useful for treating fractures
AU1646701A (en) Composition for treating respiratory tract infections
GB0127384D0 (en) Well treatment system
AU151997S (en) Respiratory mask
IL143549A0 (en) A system for veterinary treatment
AU2001258675A1 (en) Treating infections
GB2374662B (en) Air treatment system
GB2397018B (en) Combination therapy for treating disease
GB0112084D0 (en) The treatment of respiratory infections
GB0128004D0 (en) System for treatment
AU2002320308A1 (en) Drugs for treating viral infections
GB0130694D0 (en) Treatment
GB0102559D0 (en) Treatment for angiogenesis-dependant condition
CA93371S (en) Inhaler